The firm is developing protein therapies incorporating synthetic amino acids coded for by "unnatural" base pairs developed at The Scripps Research Institute.
The company said it will use the proceeds to fund its growth into new markets, and to build its next-generation automated foundry.
Researchers and business leaders unveil their plan for HGP-write to synthesize full genomes.
A proposal published in Science lays out a vision to drive down the cost of fabricating genomes and accelerate research and innovation in synthetic biology.
At a user meeting in London this week, Chief Technology Officer Clive Brown introduced the SmidgIon and a number of other technology developments, as well as a new synthetic biology spinoff.
Harvard's George Church says that a project to create synthetic human genomes at the center of last week's controversial meeting is at the 'thought experiment' stage.
Twist said it will use Genome Compiler's technology and expertise to build a portfolio of digital products, including a suite of gene design products.
Researchers have developed a programming language to design computational circuits for living cells.
The Cambridge, Massachusetts-based DNA manufacturer is looking to max out its production capacity, which works best at high volume and throughput.
Craig Venter and his colleagues develop a minimal bacterial genome of 473 genes, though the function of a third of those genes is unknown.
US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.
Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.
Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.
In Science this week: almond reference genome, and more.